Go Deep
Human Metabolome Technologies, Inc.
Human Metabolome Technologies, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,976 | 16.8 | 1.74 | 0.06 | 358.38 |
| Oct 2026 | 22,127 | 16.7 | 1.74 | 0.06 | 358.29 |
| Oct 2026 | 22,181 | 16.6 | 1.72 | 0.06 | 353.24 |
| Oct 2026 | 22,164 | 16.8 | 1.73 | 0.06 | 354.83 |
Human Metabolome Technologies, Inc. Quarterly Results
| Line Item | Sep 2025 |
|---|---|
| EPS | -17.1 |
Human Metabolome Technologies, Inc. Revenue & Profit: Last 5 Years
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Revenue | 1,421,944,000.0 | 1,455,004,000.0 | 1,345,671,000.0 | 1,299,225,000.0 | — |
| Net Profit | 200,358,000.0 | 256,420,000.0 | 243,248,000.0 | 285,758,000.0 | — |
| EPS | 35.7 | 45.0 | 41.1 | 48.4 | — |
Human Metabolome Technologies, Inc. Balance Sheet
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Total Assets | 2,280,319,000.0 | 2,374,607,000.0 | 2,603,401,000.0 | 2,291,058,000.0 | — |
| Total Liabilities | 451,389,000.0 | 466,011,000.0 | 656,690,000.0 | 518,730,000.0 | — |
| Total Equity | 1,828,930,000.0 | 1,908,596,000.0 | 1,946,711,000.0 | 1,772,328,000.0 | — |
Owes vs Owns
Human Metabolome Technologies, Inc. owed ¥0.20 for every ¥1 it owned in Jun 2026, down from ¥0.23 in Jun 2023.
| Period | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.20× | 0.20× | 0.25× | 0.23× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Human Metabolome Technologies, Inc. Assets & Liabilities Breakdown (JPY millions)
What it owns — Jun 2026
Cash & short-term investments 63.3%Receivables 11.3%Inventory 1.2%Fixed assets (tangible) 11.6%Intangible assets 1.5%Long-term investments 2.2%Other assets 8.9%
How it's funded — Jun 2026
Short-term debt 4.4%Payables 1.0%Other liabilities 14.4%Shareholders' equity 80.2%
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,444.2 | 1,562.4 | 1,788.5 | 1,656.8 |
| Receivables | 257.8 | 171.2 | 228.2 | 129.9 |
| Inventory | 27.6 | 51.2 | 37.0 | 26.2 |
| Fixed assets (tangible) | 264.4 | 285.0 | 331.9 | 270.9 |
| Intangible assets | 33.3 | 12.8 | 17.5 | 21.8 |
| Long-term investments | 50.0 | 50.0 | 7.0 | 7.0 |
| Other assets | 203.2 | 242.1 | 193.4 | 178.5 |
| Liabilities & equity | ||||
| Short-term debt | 100.0 | 100.0 | 200.0 | 200.0 |
| Long-term debt | 0.0 | 3.5 | 11.3 | 13.2 |
| Payables | 22.2 | 3.9 | 15.0 | 0.0 |
| Other liabilities | 329.2 | 358.7 | 430.3 | 305.6 |
| Shareholders' equity | 1,828.9 | 1,908.6 | 1,946.7 | 1,772.3 |
| Net tangible assets | 1,795.7 | 1,895.8 | 1,929.2 | 1,750.5 |
Human Metabolome Technologies, Inc. Cash Flow
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Operating Activities | 208,580,000.0 | 373,531,000.0 | 236,795,000.0 | 284,962,000.0 | — |
| Investing Activities | -83,370,000.0 | -197,272,000.0 | -32,441,000.0 | -116,755,000.0 | — |
| Financing Activities | -281,764,000.0 | -369,451,000.0 | -73,153,000.0 | -13,754,000.0 | — |